These findings establish the cardiomyocyte structural homeostasis via the ITGA5-DSC2 adhesion axis as a novel, key SGLT2-independent mechanism for empagliflozin’s cardioprotection, revealing promising new therapeutic approaches for sepsis-induced cardiomyopathy. The gene discussed is SLC5A2; the disease is Sepsis.